Publications in collaboration with researchers from University of Michigan–Ann Arbor (3)

2022

  1. Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial

    Nature communications, Vol. 13, Núm. 1, pp. 1878

2020

  1. Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial

    Cancer, Vol. 126, Núm. 18, pp. 4156-4167

2010

  1. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)

    Annals of Oncology, Vol. 21, Núm. 9, pp. 1794-1803